Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia

Western Galilee Hospital-Nahariya

Status and phase: Not yet enrolling; Phase 4

Conditions: Anemia, Iron Deficiency; Pregnancy Anemia

Treatments: Drug: Venofer 200 MG Per 10 ML Injection; Drug: Ferinject

Study type: Interventional

Funder types: Other

Identifiers

NCT06061393

0120-23-NHR

Details and patient eligibility

About

The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin <9 gr/dl , treated with venofer and women treated with ferinject.

Enrollment: 200 estimated patients

Sex: Female

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

pregnancy>24 weeks of gestation anemia with Hb<8 anemia with Hb<9 if symptomatic anemia of previous postpartum hemorrhage

Exclusion criteria

• Allergy to one of the study's drugs
• IV iron treatment in the last month
• chronic anemia- thalassemia, renal failure Twins pregnancy
• non iron deficiency anemia

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

200 participants in 2 patient groups

venofer

Active Comparator group

Description:

Women with iron def. anemia aith hemoglobin level \<9 gr/dl who will be traeted with venofer

Treatment:

Drug: Venofer 200 MG Per 10 ML Injection

Ferinject

Active Comparator group

Description:

Women with iron def. anemia aith hemoglobin level \<9 gr/dl who will be traeted with ferinject

Treatment:

Drug: Ferinject